• + 7 (700) 356-49-30
    + 86 13431079214
    + 86 17688273501
Call Now —
Get Expert Advice

Basis for Vulvar Cancer Diagnosis

1.Clinical presentation assessment

A detailed history focuses on pruritus and pain characteristics, and examination evaluates skin changes, mass features, and the relationship to surrounding tissues.

2.Gynecologic examination

A systematic evaluation of the vulva, vagina, and cervix assesses tumor location, size, morphology, and other abnormalities.

3.Biopsy and histopathology

The gold standard. Biopsy of suspicious tissue determines histologic type, grade, and depth of invasion.

4.Colposcopy

Magnified visualization helps localize suspicious areas and guide biopsy sampling, improving diagnostic accuracy.

5.Imaging examinations

Ultrasound, CT, or MRI assess depth of invasion, lymph node involvement, and distant spread.

6.HPV testing

High-risk HPV status supports etiologic assessment and may contribute to prognostic evaluation.

7.Tumor markers

Serologic markers such as SCC antigen may be used for monitoring and as adjuncts for diagnosis and follow-up assessment of treatment response.

8.Lymph node assessment

Ultrasound-guided needle sampling or sentinel lymph node biopsy can accurately determine nodal metastasis status.

Conclusion

Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that delayed diagnosis of vulvar cancer can result in severe local destruction, functional impairment, and even life-threatening consequences. Early and accurate diagnosis is key to improving prognosis. Women should remain vigilant for vulvar pruritus, masses, ulcers, and other abnormalities and seek prompt medical evaluation. Through standardized diagnostic pathways and MDT-based collaboration, individualized treatment strategies can maximize functional preservation and improve survival and quality of life.

Call Now —
Get Expert Advice
> Home > Cancer Types > Vulvar Cancer
Call Now —
Get Expert Advice

Basis for Vulvar Cancer Diagnosis

1.Clinical presentation assessment

A detailed history focuses on pruritus and pain characteristics, and examination evaluates skin changes, mass features, and the relationship to surrounding tissues.

2.Gynecologic examination

A systematic evaluation of the vulva, vagina, and cervix assesses tumor location, size, morphology, and other abnormalities.

3.Biopsy and histopathology

The gold standard. Biopsy of suspicious tissue determines histologic type, grade, and depth of invasion.

4.Colposcopy

Magnified visualization helps localize suspicious areas and guide biopsy sampling, improving diagnostic accuracy.

5.Imaging examinations

Ultrasound, CT, or MRI assess depth of invasion, lymph node involvement, and distant spread.

6.HPV testing

High-risk HPV status supports etiologic assessment and may contribute to prognostic evaluation.

7.Tumor markers

Serologic markers such as SCC antigen may be used for monitoring and as adjuncts for diagnosis and follow-up assessment of treatment response.

8.Lymph node assessment

Ultrasound-guided needle sampling or sentinel lymph node biopsy can accurately determine nodal metastasis status.

Conclusion

Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that delayed diagnosis of vulvar cancer can result in severe local destruction, functional impairment, and even life-threatening consequences. Early and accurate diagnosis is key to improving prognosis. Women should remain vigilant for vulvar pruritus, masses, ulcers, and other abnormalities and seek prompt medical evaluation. Through standardized diagnostic pathways and MDT-based collaboration, individualized treatment strategies can maximize functional preservation and improve survival and quality of life.

Call Now —
Get Expert Advice